Organized by the Japan Alliance on Global NTDs, the theme of this webinar series is ‘Challenges of expanding access to health products in the fight against neglected tropical diseases‘ and aims clarify some conceptual aspects about access, discuss key access challenges from different perspectives and how these can be overcome.
The second session of the series focuses on fexinidazole, the first all-oral treatment for human African trypanosomiasis developed in partnership by DNDi, Sanofi, and many other organizations.
Date: Thursday, 14 October 2021
Time: 16: 00-17: 00 (Japan time)
Speakers:
- Olaf Valverde, Clinical Project Leader (HAT), DNDi
- Florent Mbo, HAT Platform Coordinator and Access Senior Project Manager, DNDi
